Oxford Biomedica plc (LON:OXB)

Oxford Biomedica Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	364	445	213	426	1,059	848
Market Cap Growth	108.92%	108.92%	-50.00%	-59.79%	24.98%	71.01%
Enterprise Value	416	479	223	453	1,008	808
Last Close Price	3.44	4.20	2.20	4.42	12.30	10.30
PE Ratio	-	-	-	-	55.72	-
Forward PE	-	-	-	-	60.29	-
PS Ratio	2.83	3.46	2.38	3.04	7.42	9.66
PB Ratio	6.02	7.36	2.74	1.80	5.66	7.52
P/TBV Ratio	13.10	15.99	4.95	4.31	5.66	7.52
P/FCF Ratio	-	-	-	-	66.23	-
P/OCF Ratio	-	-	-	-	41.62	272.03
EV/Sales Ratio	3.23	3.72	2.49	3.24	7.06	9.21
EV/EBITDA Ratio	-	-	-	-	30.85	224.65
EV/EBIT Ratio	-	-	-	-	45.53	-
EV/FCF Ratio	-7.15	-	-	-	63.01	-
Debt / Equity Ratio	1.80	1.80	1.43	0.48	0.05	0.12
Debt / EBITDA Ratio	-	-	-	-	0.27	2.78
Debt / FCF Ratio	-	-	-	-	0.58	-
Asset Turnover	0.53	0.53	0.25	0.40	0.68	0.57
Inventory Turnover	5.73	5.73	3.91	6.40	7.32	8.78
Quick Ratio	1.98	1.98	2.80	3.33	4.54	1.88
Current Ratio	2.28	2.28	3.19	3.61	4.92	2.06
Return on Equity (ROE)	-70.28%	-70.28%	-117.29%	-21.32%	12.67%	-6.63%
Return on Assets (ROA)	-9.76%	-9.76%	-15.07%	-8.33%	6.57%	-1.98%
Return on Capital (ROIC)	-13.18%	-13.18%	-19.89%	-10.61%	8.56%	-2.89%
Return on Capital Employed (ROCE)	-	-	-	-	10.90%	-
Earnings Yield	-11.85%	-9.71%	-73.95%	-9.19%	1.80%	-0.74%
FCF Yield	-15.96%	-13.07%	-18.01%	-6.79%	1.51%	-1.21%
Buyback Yield / Dilution	-7.15%	-7.15%	-1.82%	-10.76%	-7.10%	-9.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.